Zobrazeno 1 - 10
of 205
pro vyhledávání: '"B. A. van Hout"'
Publikováno v:
Rheumatology. 46:1320-1328
OBJECTIVES This study evaluated the cost effectiveness of adalimumab vs conventional therapy in patients with active ankylosing spondylitis (AS). METHODS The analysis was based on pooled data from two Phase III studies of adalimumab in active AS. Pat
Autor:
M. van den Brand, M.C. Morice, B A van Hout, Wietze Lindeboom, Pedro A. Lemos, P. W. Serruys, G-A van Es
Publikováno v:
Heart, 91(4), 507-512. BMJ PUBLISHING GROUP
Objective: To assess the balance between costs and effects of the sirolimus eluting stent in the treatment of single native de novo coronary lesions in the RAVEL ( randomised study with the sirolimus eluting Bx Velocity balloon expandable stent in th
Publikováno v:
Heart, 90, 995-998. BMJ Publishing Group
Heart, 90(9), 995-998. BMJ PUBLISHING GROUP
Heart, 90(9), 995-998. BMJ PUBLISHING GROUP
In-stent restenosis and the need of repeat revascularisation remain the major limitations of coronary angioplasty for patients with multivessel disease.1,2 Utilisation of drug eluting stents in this context is expected to have a major impact on the e
Publikováno v:
Alimentary Pharmacology & Therapeutics. 17:1237-1245
Background: Proton pump inhibitors have a prominent role in the management of acid-related diseases. Controlling expenses on proton pump inhibitors would yield great economic benefits for Dutch health care. Aim: To investigate whether clinical differ
Publikováno v:
Acta Radiologica. 43:528-532
Purpose: To assess and quantify the association of haemophilic arthropathy, measured by the radiological Pettersson score, with the number of joint bleeds suffered by the patient. Material and Methods: In order to quantify the effect of the cumulativ
Autor:
B A van Hout, J.E.F. Zwart-van Rijkom
Publikováno v:
European Heart Journal. 22:1476-1484
Aims The EPISTENT study has demonstrated that the combined use of abciximab and stenting as an adjunct to PTCA leads to increased event-free survival compared to either using abciximab or stenting alone. However, this combined strategy may be costly
Publikováno v:
Journal of Internal Medicine, 248(2), 143-150. Wiley-Blackwell Publishing Ltd
Journal of internal medicine, 248(2), 143-150. Wiley-Blackwell
Journal of internal medicine, 248(2), 143-150. Wiley-Blackwell
Moerman CJ, van Hout BA, Bonneux L,Witteman JCM (University of Amsterdam, Amster-dam, and Erasmus University Medical School,Rotterdam, the Netherlands). Postmenopausal hor-mone therapy: less favourable risk–benefit ratios inhealthy Dutch women. J I
Publikováno v:
Therapeutic drug monitoring, 21(1), 63-73. Lippincott Williams and Wilkins
The benefits of a pharmacy-based, active therapeutic drug monitoring (TDM) service (ATM) on outcomes were examined in a prospective study at four hospitals. ATM involved pharmacokinetic dosage optimization at the start of treatment, subsequent Bayesi
Publikováno v:
BMJ. 315:221-225
Objective: To determine the relative contribution of decline in bone density to the increase in risk of hip fracture with age in men and women. Design: Incidence data of hip fracture from the general population were combined with the bone density dis
Publikováno v:
Epilepsia. 38:S1-S8
Cost of illness, quality of life (QOL), and sudden unexpected death in epilepsy are disease-related issues that have become increasingly prominent. Because new treatments for epilepsy are now becoming widely available, it is useful to attempt to dete